BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15046390)

  • 1. Current approaches to the treatment of well-differentiated thyroid cancer.
    Angelos P
    Oncology (Williston Park); 2002 Mar; 16(3):309-15; discussion 315, 318, 323-4. PubMed ID: 15046390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
    McHenry CR; Sandoval BA
    Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of surgery for differentiated thyroid cancer.
    Dackiw AP; Zeiger M
    Surg Clin North Am; 2004 Jun; 84(3):817-32. PubMed ID: 15145237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Follow-up care for differentiated thyroid cancer].
    Hüfner M; Reiners C
    Dtsch Med Wochenschr; 1986 Nov; 111(45):1732-4. PubMed ID: 3536387
    [No Abstract]   [Full Text] [Related]  

  • 7. [Taking of position in relationship to the protocol of the current treatment of thyroid nodules and differentiated thyroid cancer].
    Gómez Sáez JM
    Endocrinol Nutr; 2010 Oct; 57(8):370-5. PubMed ID: 20850397
    [No Abstract]   [Full Text] [Related]  

  • 8. Total thyroidectomy for differentiated thyroid cancer.
    Sosa JA; Udelsman R
    J Surg Oncol; 2006 Dec; 94(8):701-7. PubMed ID: 17131393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular and Hürthle cell carcinoma of the thyroid gland.
    Phitayakorn R; McHenry CR
    Surg Oncol Clin N Am; 2006 Jul; 15(3):603-23, ix-x. PubMed ID: 16882500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing concepts in the management of differentiated thyroid cancer.
    Intenzo CM; Jabbour S; Dam HQ; Capuzzi DM
    Semin Nucl Med; 2005 Oct; 35(4):257-65. PubMed ID: 16150246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus conference on well-differentiated thyroid cancer: a summary.
    Pasieka JL; Rotstein LE
    Can J Surg; 1993 Aug; 36(4):298-301. PubMed ID: 8370008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
    Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
    Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of total thyroidectomy in the management of differentiated thyroid cancer.
    Stephenson BM; Wheeler MH; Clark OH
    Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large remnant 131I ablation as an alternative to completion/total thyroidectomy in the treatment of well-differentiated thyroid cancer.
    Leblanc G; Tabah R; Liberman M; Sampalis J; Younan R; How J
    Surgery; 2004 Dec; 136(6):1275-80. PubMed ID: 15657587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer.
    Hamy A; Mirallié E; Bennouna J; Resche I; Drefty C; Johnstone M; Visset J
    Eur J Surg Oncol; 2004 Aug; 30(6):681-5. PubMed ID: 15256244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well-differentiated thyroid cancer.
    Aiello DP; Manni A
    Arch Intern Med; 1990 Feb; 150(2):437-9. PubMed ID: 2105703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Well-differentiated thyroid carcinoma].
    Feigl D; Chamovitz DL; Harell M; Gewurtz G; Zaidel L; Fogelfeld L
    Harefuah; 1989 Apr; 116(8):401-4. PubMed ID: 2744644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.